Method And Compositions For The Treatment Of Fabry Disease

NZ793215BActive Publication Date: 2026-09-01SANGAMO THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ793215
Authority / Receiving Office: NZ · NZ
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2017-08-31
Filing Date: 2017-10-19
Publication Date: 2026-09-01
Estimated Expiration: 2037-10-19

Application Information

Patent Timeline

31 Aug 2017

Priority

19 Oct 2017

Application

NZ793215

01 Sep 2026

Publication

NZ793215B

IPC: A61K48/00; C12N15/00; C12N15/87; C12P21/06

Inventors: HUSTON, MARSHALL W.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 1_ABST

Patent Text Reader

Abstract

The disclosure provides nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic alpha galactosidase A (alpha-Gal A) protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and / or prevention of Fabry disease. Further provided are compositions for expressing at least one alpha-Gal A protein.

Need to check novelty before this filing date? Find Prior Art